FCA
MRK icon

FLC Capital Advisors’s Merck MRK Stock Holding History

FLC Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
86,579
-823
-0.9% -$96.3K 1.79% 12
2026
Q1 		$10.5M Sell
87,402
-1,763
-2% -$204K 1.88% 11
2025
Q4 		$9.39M Buy
89,165
+2,558
+3% +$240K 1.73% 14
2025
Q3 		$7.27M Buy
86,607
+2,078
+2% +$171K 1.41% 19
2025
Q2 		$6.69M Buy
84,529
+4,923
+6% +$391K 1.38% 19
2025
Q1 		$7.15M Buy
79,606
+580
+0.7% +$54.2K 1.6% 16
2024
Q4 		$7.86M Sell
79,026
-2,479
-3% -$256K 1.81% 15
2024
Q3 		$9.26M Sell
81,505
-2,990
-4% -$355K 2.14% 11
2024
Q2 		$10.5M Sell
84,495
-108
-0.1% -$13.9K 2.57% 8
2024
Q1 		$11.2M Sell
84,603
-968
-1% -$119K 2.82% 8
2023
Q4 		$9.33M Buy
85,571
+2,697
+3% +$280K 2.51% 8
2023
Q3 		$8.53M Sell
82,874
-483
-0.6% -$52.1K 2.58% 8
2023
Q2 		$9.62M Hold
83,357
– – 2.81% 8
2023
Q1 		$8.87M Sell
83,357
-200
-0.2% -$21.6K 2.71% 8
2022
Q4 		$9.27M Sell
83,557
-89
-0.1% -$9.1K 2.88% 6
2022
Q3 		$7.2M Sell
83,646
-542
-0.6% -$48.4K 2.5% 10
2022
Q2 		$7.67M Sell
84,188
-1,051
-1% -$93.2K 2.56% 8
2022
Q1 		$6.99M Buy
85,239
+10,189
+14% +$803K 1.96% 13
2021
Q4 		$5.75M Buy
75,050
+1,477
+2% +$118K 1.6% 17
2021
Q3 		$5.53M Buy
73,573
+2,040
+3% +$155K 1.63% 18
2021
Q2 		$5.56M Sell
71,533
-2,202
-3% -$164K 1.64% 19
2021
Q1 		$5.42M Buy
73,735
+4,727
+7% +$349K 1.7% 17
2020
Q4 		$5.39M Buy
69,008
+3,491
+5% +$267K 1.79% 17
2020
Q3 		$4.89M Buy
65,517
+2,035
+3% +$159K 1.79% 15
2020
Q2 		$4.82M Buy
63,482
+3,388
+6% +$255K 1.91% 18
2020
Q1 		$4.41M Buy
60,094
+4,358
+8% +$343K 2.05% 12
2019
Q4 		$4.84M Sell
55,736
-969
-2% -$79.6K 1.94% 13
2019
Q3 		$4.55M Sell
56,705
-1,258
-2% -$101K 1.93% 13
2019
Q2 		$4.65M Sell
57,963
-199
-0.3% -$15.2K 1.91% 14
2019
Q1 		$4.62M Buy
58,162
+2,318
+4% +$173K 2.09% 13
2018
Q4 		$4.07M Buy
+55,844
New +$3.94M 2.74% 12

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

FLC Capital Advisors's MRK Position: Q2 2026 in Review

FLC Capital Advisors reduced its Merck (MRK) stake by 0.94% in Q2 2026, selling an estimated $96.3K and leaving 86,579 shares worth $11.1M. The position accounts for 1.79% of the portfolio, ranked #12.

FLC Capital Advisors first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.2M in Q1 2024. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FLC Capital Advisors held 86,579 shares of Merck worth $11.1M as of Q2 2026.
  • FLC Capital Advisors sold 823 Merck shares in Q2 2026, an estimated $96.3K.
  • Merck made up 1.79% of FLC Capital Advisors's portfolio in Q2 2026, its #12 holding.
  • FLC Capital Advisors first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • FLC Capital Advisors's Merck position peaked at $11.2M in Q1 2024.
  • 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.